Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial.
Nat Med
; 29(4): 888-897, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-37012549
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Antineoplastic Agents
Limits:
Humans
/
Male
Language:
En
Journal:
Nat Med
Journal subject:
BIOLOGIA MOLECULAR
/
MEDICINA
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos